HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
CytoSorbents Awarded $2,897,172 Phase III STTR Contract
This follows the successful completion of Phase I and II STTR contracts of approximately $1.15 million with researchers at Penn State University, previously funded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the U.S. Army Medical Research and Material Command (USAMRMC).
HistoSonics Announces $40 Million Financing
HistoSonics notes the breakthrough medical platform offers vision of non-invasive procedures to eliminate diseased tissues and tumors
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
During the last year, Alpha Tau Medical successfully completed its first-in-human clinical trial of Alpha DaRT with squamous cell carcinoma patients from Italy and Israel.
Base Genomics Announces Company Launch and Raises $11 Million USD
Base Genomics is led by a highly experienced team of scientists and clinicians, including Dr Vincent Smith, a world-leader in genomic product development and other prominent leaders.
LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant
This grant, the largest it has received from the Resource Center, will allow the company to conduct a pivotal animal study and generate all the other required data to file an Investigational Device Exemption (IDE) application with the FDA to start a clinical trial.
LabMinds Secures Financing to Boost Commercial Growth of The REVO® Robotic System
This funding will help drive the commercialization of its automation system as well as facilitate the expansion of LabMinds’ product portfolio.
Ezra Raises $18M Series A
The AI cancer screening startup will use the funding to expand its suite of medical imaging AIs, and launch the Ezra COVID 360 offering.
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
The funds to be used to further the development of an inactivated vaccine against COVID-19 named CoronaVac. The two investors each loaned USD $7.5 million in the form of a convertible loan that bears interest, or, at the investor’s election, converts into 7.5% of the total equity interest of Sinovac R&D.
SOLIUS Announces Investment from Human Longevity Inc. to Support Mission of Improving Health, Performance, and Longevity
SOLIUS technology stimulates the production of vitamin D in the skin using a narrow spectrum of ultraviolet B (UVB) light.